ST
SEEKYO is developing targeted chemotherapies that utilize novel drug delivery systems to enhance the efficacy of cancer treatment while minimizing side effects. The company focuses on improving patient outcomes by increasing the precision of drug administration to tumor sites.
Updated 4 months ago
Funding
$774.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- SEEKYO is developing targeted chemotherapies that utilize novel drug delivery systems to enhance the efficacy of cancer treatment while minimizing side effects. The company focuses on improving patient outcomes by increasing the precision of drug administration to tumor sites.